131 related articles for article (PubMed ID: 16670333)
1. Reevaluation of P-selectin and alpha 4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis.
Kerfoot SM; Norman MU; Lapointe BM; Bonder CS; Zbytnuik L; Kubes P
J Immunol; 2006 May; 176(10):6225-34. PubMed ID: 16670333
[TBL] [Abstract][Full Text] [Related]
2. Overlapping roles of P-selectin and alpha 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis.
Kerfoot SM; Kubes P
J Immunol; 2002 Jul; 169(2):1000-6. PubMed ID: 12097407
[TBL] [Abstract][Full Text] [Related]
3. Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines.
Engelhardt B
J Neurol Sci; 2008 Nov; 274(1-2):23-6. PubMed ID: 18573502
[TBL] [Abstract][Full Text] [Related]
4. E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice.
Döring A; Wild M; Vestweber D; Deutsch U; Engelhardt B
J Immunol; 2007 Dec; 179(12):8470-9. PubMed ID: 18056394
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment.
Brocke S; Piercy C; Steinman L; Weissman IL; Veromaa T
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6896-901. PubMed ID: 10359810
[TBL] [Abstract][Full Text] [Related]
6. Critical role of the alpha 4 integrin/VCAM-1 pathway in cerebral leukocyte trafficking in lupus-prone MRL/fas(lpr) mice.
James WG; Bullard DC; Hickey MJ
J Immunol; 2003 Jan; 170(1):520-7. PubMed ID: 12496439
[TBL] [Abstract][Full Text] [Related]
7. P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice.
Engelhardt B; Kempe B; Merfeld-Clauss S; Laschinger M; Furie B; Wild MK; Vestweber D
J Immunol; 2005 Jul; 175(2):1267-75. PubMed ID: 16002731
[TBL] [Abstract][Full Text] [Related]
8. Epithelial V-like antigen mediates efficacy of anti-alpha₄ integrin treatment in a mouse model of multiple sclerosis.
Wright E; Rahgozar K; Hallworth N; Lanker S; Carrithers MD
PLoS One; 2013; 8(8):e70954. PubMed ID: 23951051
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms underlying IL-4-induced leukocyte recruitment in vivo: a critical role for the alpha 4 integrin.
Hickey MJ; Granger DN; Kubes P
J Immunol; 1999 Sep; 163(6):3441-8. PubMed ID: 10477616
[TBL] [Abstract][Full Text] [Related]
10. IVIg therapy in brain inflammation: etiology-dependent differential effects on leucocyte recruitment.
Lapointe BM; Herx LM; Gill V; Metz LM; Kubes P
Brain; 2004 Dec; 127(Pt 12):2649-56. PubMed ID: 15355874
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats.
van der Laan LJ; van der Goes A; Wauben MH; Ruuls SR; Döpp EA; De Groot CJ; Kuijpers TW; Elices MJ; Dijkstra CD
J Neurosci Res; 2002 Jan; 67(2):191-9. PubMed ID: 11782963
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors.
Piccio L; Rossi B; Scarpini E; Laudanna C; Giagulli C; Issekutz AC; Vestweber D; Butcher EC; Constantin G
J Immunol; 2002 Feb; 168(4):1940-9. PubMed ID: 11823530
[TBL] [Abstract][Full Text] [Related]
13. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease.
Kerfoot SM; Long EM; Hickey MJ; Andonegui G; Lapointe BM; Zanardo RC; Bonder C; James WG; Robbins SM; Kubes P
J Immunol; 2004 Dec; 173(11):7070-7. PubMed ID: 15557205
[TBL] [Abstract][Full Text] [Related]
14. Efficient recruitment of lymphocytes in inflamed brain venules requires expression of cutaneous lymphocyte antigen and fucosyltransferase-VII.
Piccio L; Rossi B; Colantonio L; Grenningloh R; Gho A; Ottoboni L; Homeister JW; Scarpini E; Martinello M; Laudanna C; D'Ambrosio D; Lowe JB; Constantin G
J Immunol; 2005 May; 174(9):5805-13. PubMed ID: 15843584
[TBL] [Abstract][Full Text] [Related]
15. Humanization of a mouse antibody against human alpha-4 integrin: a potential therapeutic for the treatment of multiple sclerosis.
Léger OJ; Yednock TA; Tanner L; Horner HC; Hines DK; Keen S; Saldanha J; Jones ST; Fritz LC; Bendig MM
Hum Antibodies; 1997; 8(1):3-16. PubMed ID: 9265500
[TBL] [Abstract][Full Text] [Related]
16. Adhesion molecule phenotype of T lymphocytes in inflamed CNS.
Engelhardt B; Martin-Simonet MT; Rott LS; Butcher EC; Michie SA
J Neuroimmunol; 1998 Apr; 84(1):92-104. PubMed ID: 9600713
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of tumor necrosis factor alpha-stimulated leukocyte recruitment into the murine hepatic circulation.
Fox-Robichaud A; Kubes P
Hepatology; 2000 May; 31(5):1123-7. PubMed ID: 10796888
[TBL] [Abstract][Full Text] [Related]
18. Alpha4beta1 integrin mediates the recruitment of immature dendritic cells across the blood-brain barrier during experimental autoimmune encephalomyelitis.
Jain P; Coisne C; Enzmann G; Rottapel R; Engelhardt B
J Immunol; 2010 Jun; 184(12):7196-206. PubMed ID: 20483748
[TBL] [Abstract][Full Text] [Related]
19. PSGL-1 is dispensible for the development of active experimental autoimmune encephalomyelitis in SJL/J mice.
Bill R; Döring A; Deutsch U; Engelhardt B
J Neuroimmunol; 2011 Mar; 232(1-2):207-8. PubMed ID: 21051092
[TBL] [Abstract][Full Text] [Related]
20. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis.
Constantin G; Marconi S; Rossi B; Angiari S; Calderan L; Anghileri E; Gini B; Bach SD; Martinello M; Bifari F; Galiè M; Turano E; Budui S; Sbarbati A; Krampera M; Bonetti B
Stem Cells; 2009 Oct; 27(10):2624-35. PubMed ID: 19676124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
